Recruiting Clinical Trials
Showing 183 Clinical Trials-
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Start Date: June 2021 Updated: July 2021
Berlin, Germany
Mannheim, Baden-Württemberg, GermanyPsilocybin
All
25 Years to 65 Years (Adult, Older Adult)
-
Start Date: May 2017 Updated: May 2020
Birmingham, Alabama, USAKetamine
All
18 Years to 100 Years (Adult, Older Adult)
-
Start Date: January 2020 Updated: February 2020
Winterthur, Zürich, SwitzerlandKetamine
Female
18 Years and older (Adult, Older Adult)
-
Start Date: October 2017 Updated: April 2020
Saskatoon, Saskatchewan, CanadaKetamine
All
up to 12 Years (Child)
-
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
Start Date: November 2018 Updated: December 2021
New Haven, Connecticut, USAPsilocybin
All
21 Years to 65 Years (Adult, Older Adult)
-
Start Date: June 2016 Updated: August 2020
Dallas, Texas, USAKetamine
All
18 Years and older (Adult, Older Adult)
-
Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)
Start Date: March 2020 Updated: July 2020
Bandar Tun Razak, Kuala Lumpur, MalaysiaKetamine
All
16 Years and older (Child, Adult, Older Adult)
-
Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder
Start Date: March 2022 Updated: May 2022
Gainesville, Florida, USAPsilocybin
All
18 Years to 64 Years (Adult)
-
Evaluation of the Initial Prescription of Ketamine and Milnacipran for Depression in Palliative Care
Start Date: September 2016 Updated: December 2018
Lille, Hauts-de-France, France
Valenciennes, Hauts-de-France, FranceKetamine
All
18 Years and older (Adult, Older Adult)
-
Start Date: July 2020 Updated: December 2021
Zagazig, Sharqia, EgyptKetamine
All
18 Years and older (Adult, Older Adult)